Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model [version 2; referees: 3 approved]

Autor: Ruth Young, Tewodros Bekele, Alexander Gunn, Nick Chapman, Vipul Chowdhary, Kelsey Corrigan, Lindsay Dahora, Sebastián Martinez, Sallie Permar, Johan Persson, Bill Rodriguez, Marco Schäferhoff, Kevin Schulman, Tulika Singh, Robert F Terry, Gavin Yamey

Publikováno v: Gates Open Research, Vol 2 (2018)

Background: Funding for neglected disease product development fell from 2009-2015, other than a brief injection of Ebola funding. One impediment to mobilizing resources is a lack of information on product candidates, the estimated costs to move them

Externí odkaz: https://doaj.org/article/d031e1cfda204999b06d7ac4a6f5fa93

Flavivirus Serologic Surveillance: Multiplex Sample-Sparing Assay for Detecting Type-Specific Antibodies to Zika and Dengue Viruses

Autor: Lindsay Dahora, Izabella N. Castillo, Freddy A. Medina, Frances Vila, Jorge Munoz-Jordan, Bruno Segovia, Aravinda M. deSilva, Lakshmanane Premkumar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::45dc8f4b66c665e23b22ebad729bc31e
https://doi.org/10.2139/ssrn.4411430

Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protection.

Autor: Katzelnick L; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Odio C; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Daag J; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila, Manila, Philippines., Crisostomo MV; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila, Manila, Philippines., Voirin C; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Escoto AC; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Adams C; University of North Carolina at Chapel Hill., Hein LD; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill., Aogo R; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Mpingabo P; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Rodriguez GR; Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health., Firdous S; National Institute of Allergy and Infectious Diseases., Fernandez MA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill., White L; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill., Agrupis KA; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila., Deen J; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila., de Silva A; University of North Carolina at Chapel Hill., Ylade M; Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines Manila.

Publikováno v: Research square [Res Sq] 2024 Apr 12. Date of Electronic Publication: 2024 Apr 12.